PDO Based Drug Sensitive Test in R/M SGC — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

PDO Based Drug Sensitive Test in R/M SGC — Stella

Recruiting

Back to Salivary Gland Cancers trials

Trial locations(2 sites)

China

Huashan Hospital, Fudan University, Shanghai, Shanghai Municipality

Huashan Hospital, Fudan University, Shanghai, Shanghai Municipality

Key details

Sponsor

Huashan Hospital

Collaborators

Shanghai Cancer Hospital, China, Eye & ENT Hospital of Fudan University

Enrollment target

~40 participants

Started

March 2025

Primary completion

November 2026

Age range

18 Years – 80 Years

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov